CLINICAL_TRIALS
trial_result
· 2015-10-30
Clinical Trial Update: A Study Comparing Vemurafenib Versus Vemurafenib Plus Cobimetinib in Participants With Metastatic Melanoma [Phase 3]
Summary
A Phase 3 trial comparing vemurafenib alone versus vemurafenib with cobimetinib in metastatic melanoma has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Malignant Melanoma | Phase 3 | Status: COMPLETED | Results posted: 2015-10-30